NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/20/2022
Back to search
Official data from USPTO
N-CODER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
12/20/2022
Trademark type
Word
Nice classes
1, 5
Filing date
05/20/2021
Registration date
12/20/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/20/2022
Last transaction
12/20/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Lund, SE
Examiner
FOSTER, SHATONI A
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
BioInvent International AB
Representatives
Nancy DiConza FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical preparationsantibodies and antibody genes stored within phages to be used in scientificlaboratory and medical research; active chemical ingredients for use in the manufacture of pharmaceuticals for treating oncological diseases; libraries and collections of aforementioned chemicals for scientificlaboratory and medical research; biochemicalsantibodies for scientificlaboratory and medical research; libraries and collections of antibodies for scientificlaboratory and medical research; libraries and collections of antibodiescollections of antibodies and antibody genes stored in phages in test tubes for scientificlaboratory and medical research purposes; active chemical ingredients for use in the manufacture of pharmaceuticals for treating oncological diseasescollections of antibodies and antibody genes stored in phages in test tubes
Class 5
Antibodiespeptidesproteinsnucleic acidsgenes and oligonucleotides of human originall of the aforesaid being chemical preparations for clinicaltherapeuticdiagnostic medical use in relation to the diagnosis and treatment of oncological diseases; chemical preparationsantibodies for clinicaltherapeutic and medical diagnostic purposes; libraries and collections of antibodiescollections of antibodies and antibody genes stored in phages in test tubes for medical purposes
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/20/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/04/2022
PUBO
PUBLISHED FOR OPPOSITION
10/04/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/14/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
08/31/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
08/26/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/25/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/01/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/01/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/01/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/02/2022
GNRT
NON-FINAL ACTION E-MAILED
02/02/2022
CNRT
NON-FINAL ACTION WRITTEN
02/02/2022
DOCK
ASSIGNED TO EXAMINER
02/01/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/17/2021
NWAP
NEW APPLICATION ENTERED
05/26/2021
Continuous trademark protection
Get notified about every new filing that threatens N-CODER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.